Nu Skin Enterprises (NYSE:NUS - Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Monday morning. The company provided earnings per share guidance of 0.290-0.290 for the period, compared to the consensus earnings per share estimate of 0.250. The company issued revenue guidance of $445.0 million-$445.0 million, compared to the consensus revenue estimate of $433.8 million.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on NUS shares. DA Davidson dropped their target price on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating for the company in a research report on Friday, December 20th. StockNews.com upgraded Nu Skin Enterprises from a "hold" rating to a "buy" rating in a report on Monday, November 11th. Finally, Citigroup decreased their target price on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a "neutral" rating on the stock in a research note on Tuesday, October 22nd.
Get Our Latest Report on Nu Skin Enterprises
Nu Skin Enterprises Stock Up 10.0 %
NUS stock traded up $0.62 on Monday, reaching $6.84. 1,081,067 shares of the company traded hands, compared to its average volume of 1,248,267. Nu Skin Enterprises has a one year low of $5.95 and a one year high of $19.30. The company has a market cap of $340.02 million, a P/E ratio of -3.30 and a beta of 1.19. The firm has a fifty day simple moving average of $7.14 and a 200-day simple moving average of $8.09. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.93 and a quick ratio of 1.20.
Nu Skin Enterprises Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 11th. Investors of record on Friday, November 29th were issued a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.51%. The ex-dividend date of this dividend was Friday, November 29th. Nu Skin Enterprises's payout ratio is -11.59%.
About Nu Skin Enterprises
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Read More
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
